CannaPharmaRx, Inc. (CPMD) income statement
CPMDOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 17, 2026Score 1/30
$0.00+0.00 (0.00%)
Close on Oct 16, 2026Market cap $2.54MP/E –Yield –
CannaPharmaRx, Inc. income statement
Ratios
Latest available, balances at Sep 30, 2026
Profitability, TTM
- Gross margin
- -130.7%
- Operating margin
- -210.8%
- Net margin
- -779.2%
- Return on equity, FY2025
- 44.6%
Financial strength
- Current ratio
- 0.05
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 0.1%
Valuation
- P/E ratio
- –
- Price to sales
- 2.15
- Price to book
- –
- Dividend yield
- –
See a number that looks wrong?